Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2011 3
2012 2
2013 7
2014 3
2015 3
2017 4
2018 9
2019 5
2020 22
2021 26
2022 24
2023 25
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Multimodal kreftbehandling av gastrointestinal stromal tumor.
Hompland I, Hølmebakk T, Boye K, Stoldt S, Bjerkehagen B, Berner JM, Wiedswang AM, Revheim ME, Poulsen JP, Hall KS, Bruland ØS. Hompland I, et al. Among authors: revheim me. Tidsskr Nor Laegeforen. 2018 Oct 1;138(15). doi: 10.4045/tidsskr.18.0200. Print 2018 Oct 2. Tidsskr Nor Laegeforen. 2018. PMID: 30277049 Free article. Review. Norwegian.
Passive Alzheimer's immunotherapy: A promising or uncertain option?
Høilund-Carlsen PF, Revheim ME, Costa T, Alavi A, Kepp KP, Sensi SL, Perry G, Robakis NK, Barrio JR, Vissel B. Høilund-Carlsen PF, et al. Among authors: revheim me. Ageing Res Rev. 2023 Sep;90:101996. doi: 10.1016/j.arr.2023.101996. Epub 2023 Jul 5. Ageing Res Rev. 2023. PMID: 37414156 Review.
NaF-PET Imaging of Atherosclerosis Burden.
Høilund-Carlsen PF, Piri R, Gerke O, Sturek M, Werner TJ, Revheim ME, Alavi A. Høilund-Carlsen PF, et al. Among authors: revheim me. J Imaging. 2023 Jan 30;9(2):31. doi: 10.3390/jimaging9020031. J Imaging. 2023. PMID: 36826950 Free PMC article. Review.
FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer Disease.
Høilund-Carlsen PF, Revheim ME, Alavi A, Barrio JR. Høilund-Carlsen PF, et al. Among authors: revheim me. Clin Nucl Med. 2023 Aug 1;48(8):689-691. doi: 10.1097/RLU.0000000000004710. Epub 2023 May 23. Clin Nucl Med. 2023. PMID: 37314733 Free PMC article.
Tau Imaging in Head Injury.
Ayubcha C, Moghbel M, Borja AJ, Newberg A, Werner TJ, Alavi A, Revheim ME. Ayubcha C, et al. Among authors: revheim me. PET Clin. 2021 Apr;16(2):249-260. doi: 10.1016/j.cpet.2020.12.009. PET Clin. 2021. PMID: 33648666 Free article. Review.
Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village.
Høilund-Carlsen PF, Alavi A, Barrio JR, Castellani RJ, Costa T, Herrup K, Kepp KP, Neve RL, Perry G, Revheim ME, Robakis NK, Sensi SL, Vissel B. Høilund-Carlsen PF, et al. Among authors: revheim me. Ageing Res Rev. 2024 Jan;93:102173. doi: 10.1016/j.arr.2023.102173. Epub 2023 Dec 15. Ageing Res Rev. 2024. PMID: 38104639 Free article. Review.
Therapeutics + diagnostics = theranostics.
Haslerud T, Revheim MR. Haslerud T, et al. Among authors: revheim mr. Tidsskr Nor Laegeforen. 2023 Jan 9;143(1). doi: 10.4045/tidsskr.22.0776. Print 2023 Jan 17. Tidsskr Nor Laegeforen. 2023. PMID: 36655959 Free article. English, Norwegian. No abstract available.
Re: Aducanumab-Related ARIA: Paean or Lament?
Høilund-Carlsen PF, Alavi A, Revheim ME. Høilund-Carlsen PF, et al. Among authors: revheim me. Clin Nucl Med. 2023 Jun 1;48(6):505-506. doi: 10.1097/RLU.0000000000004509. Epub 2023 Feb 1. Clin Nucl Med. 2023. PMID: 36724162 Free PMC article. No abstract available.
Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation.
Nørgaard JN, Abildgaard N, Lysén A, Tsykunova G, Vangsted AJ, João C, Remen N, Nielsen LK, Osnes L, Stokke C, Connelly JP, Revheim MR; Nordic Myeloma Study Group (NMSG); Schjesvold F. Nørgaard JN, et al. Among authors: revheim mr. Leukemia. 2023 Oct;37(10):2107-2114. doi: 10.1038/s41375-023-01998-7. Epub 2023 Aug 11. Leukemia. 2023. PMID: 37568010 Clinical Trial.
119 results